2010: Balancing of benefits and harms in health system decision-making / Data transparency as a precondition to the informed balancing of benefits and harms

Presentations:

Friday, 19. November 2010 - Balancing of benefits and harms in health system decision-making

  •  How evidence-based can the balancing of benefits and harms be? (German)
  •  Measurement of quality of life as a method for balancing benefits and harms? (German)
  •  Differences between the balancing of risks and benefits (acc. to German Drug Law) and benefits and harms (acc. to Social Code Book V) (German)
  •  Benefits and harms - two sides of the same coin? (German)
  •  Balancing of benefits and harms in palliative medicine (German)
  •  Balancing of benefits and harms of population-based measures using the example of cancer screening (German)

Saturday, 20. November 2010 Data transparency as a precondition to the informed balancing of benefits and harms

  •  Legal regulations on data transparency - Comparison between the United States and Europe (German)
  •  Data transparency in the field of medical devices (proposals by the medical device industry) (German)
  •  Publication bias in studies beyond RCTs (German)
  •  Implications of publication bias for the development and assessment of clinical practice guidelines (German)
  •  Data transparency - an ethical imperative (German)

Further information: